235 related articles for article (PubMed ID: 9270645)
1. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
[TBL] [Abstract][Full Text] [Related]
2. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
3. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O
J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409
[TBL] [Abstract][Full Text] [Related]
4. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
[TBL] [Abstract][Full Text] [Related]
5. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
6. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
[TBL] [Abstract][Full Text] [Related]
7. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
9. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
[TBL] [Abstract][Full Text] [Related]
10. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
11. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
[TBL] [Abstract][Full Text] [Related]
12. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
[TBL] [Abstract][Full Text] [Related]
14. [Effect of aprotinin on bleeding during and graft patency after coronary artery bypass grafting].
Minohara S; Asada K; Kondo K; Tatsumi T; Hasegawa S; Sawada Y; Morimoto T; Matsuyama N; Sasaki S
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):821-4. PubMed ID: 9217377
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
[TBL] [Abstract][Full Text] [Related]
17. Effects of half-dose aprotinin in off-pump coronary artery bypass grafting.
Wei M; Jian K; Guo Z; Li P; Han J; Cai Z; Tarkka M
World J Surg; 2006 Jun; 30(6):1108-14. PubMed ID: 16736344
[TBL] [Abstract][Full Text] [Related]
18. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.
Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA; Øystese R; Istad R
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):545-8. PubMed ID: 20067988
[TBL] [Abstract][Full Text] [Related]
19. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
20. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
Mastroroberto P; Chello M; Zofrea S; Marchese AR
Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]